Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "Tecfidera"

Why Tecfidera Drug Label Is Updated...
RTTNews.com

FDA updates label for Biogen MS pill due to Brain infection case

Federal regulators are updating the label for Biogen Idec Inc.'s hot-selling multiple sclerosis pill Tecfidera to describe the recent case of a patient taking the drug who developed a rare brain infection and died. In a safety alert posted Tuesday, ... Boston Globe, 3 weeks ago
Why Tecfidera Drug Label Is Updated... RTTNews.com, 3 weeks ago

21 images for Tecfidera

Nasdaq, 3 days ago
HCPLive, 1 week ago
RTTNews.com, 3 weeks ago
FDA News, 2 weeks ago
FDA News, 2 weeks ago
Pharma Letter, 3 weeks ago
KXXV-TV, 3 weeks ago
Sys-Con Media, 3 weeks ago
I Stock Analyst, 3 weeks ago
PR Newswire, 3 weeks ago
CNBC

Biogen Falls On Patient's Death

Biogen stock traded down 5% yesterday following the announcement that a patient administered with Tecfidera, the company's MS drug, died after developing a brain infection Page 1 of 2 Click Ticker to See live coverage Biogen Idec Inc ( ...
 Bidness Etc1 month ago Biogen Falls After Patient Taking Top-Selling Tecfidera Dies  Washington Post2 months ago Hot Biogen shares fall after Tecfidera patient dies  CNBC2 months ago Biogen Beats Q3 Estimates On Strong Tecfidera Sales  Bidness Etc2 months ago
[x]  
EuroInvestor

Forward Pharma Files Lawsuit Against Biogen Over Tecfidera Sales In Germany

Forward Pharma A/S (FWP: Quote) said Tuesday it has filed a lawsuit against Biogen Idec GmbH, Biogen Idec International GmbH and Biogen Idec Ltd (BIIB) in the Regional Court in Dusseldorf, alleging infringement of its German utility model DE 20 2005 ...
 RTTNews.com1 month ago Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany  Vision Monday1 month ago Forward Pharma : Sues Biogen Idec Over Tecfidera(R) Sales in Germany  4 Traders1 month ago Forward Pharma's Threat To Biogen Idec's Tecfidera  Seeking Alpha2 months ago
[x]  
HCPLive

FDA Issues Drug Safety Communication for Multiple Sclerosis Drug Tecfidera

The US Food and Drug Administration (FDA) issued a safety announcement about Biogen Idec's drug Tecfidera (dimethyl fumarate). The warning came November 25, after a 54 year old female patient with multiple sclerosis (MS) developed a rare brain ...
 HCPLive1 week ago Serious Brain Infection Reported With Multiple Sclerosis Drug Use  Pharmacy Times3 weeks ago Tenth drug for relapsing remitting MS now available in the UK  Multiple Sclerosis Trust3 weeks ago Tecfidera now available from the NHS in England and Wales  Multiple Sclerosis Society3 weeks ago
[x]  
FDA News

FDA Warns of Rare Brain Infection Associated With MS Drug Tecfidera

The FDA has added a warning about risks of a rare brain infection associated with Biogen Idec's multiple sclerosis drug Tecfidera, after the first confirmed death of a patient taking the drug. The MS patient who acquired progressive multifocal ...
 FDA News2 weeks ago FDA Warns of PML Risk With Tecfidera in MS  Diabetes Care3 weeks ago FDA warns about case of rare brain infection PML with MS drug Tecfidera (BIIB)  Financial Content3 weeks ago FDA warning: Case of rare brain infection PML with MS drug Tecfidera  Formulary Journal3 weeks ago
[x]  
European Medicines Agency

Inform Patients of PML Case With Tecfidera in MS

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is advising physicians to inform their patients about a fatal case of progressive multifocal leukoencephalopathy (PML) in a patient being treated with dimethyl ...
 Medscape1 month ago News and press releases: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 November 2014  European Medicines Agency1 month ago Highlights of EMA Pharmacovigilance unit meeting  Pharma Letter1 month ago

Biogen Decline Over PML Tied To Tecfidera, Offers Investors A Lower Entry Point

Summary Biogen reported strong Q3 earnings. While the stock price has risen over 24% in the last year, the valuation still looks reasonable. Analysts have raised their earnings estimates 6.1% this year and 3.4% next year. Biogen is up more than ...
 Seeking Alpha1 month ago
Seeking Alpha

Biogen: Nothing To Worry About

Summary Tecfidera's sales grew 175% since the same period last year. Tecfidera's future outlook is positive since the drug's efficacy is better than its competitors and the market for multiple sclerosis is growing. Multiple Sclerosis affects ...
 Seeking Alpha1 month ago

Biogen Falls on Concerns Regarding Tecfidera Sales and PML Case

Despite posting better-than-expected earnings, Biogen Idec's ( BIIB ) shares fell 5.4% immediately after the release of third quarter results. Although shares recovered slightly in the subsequent trading session, the overall decline is approximately ...
 Yahoo! Finance1 month ago
[x]  
Boston Globe

FDA updates Tecfidera label with info on patient's death from PML

Biogen Idec ( $BIIB ) reported last month that a patient taking its hot multiple sclerosis pill Tecfidera had developed a rare brain infection and died. Now, the FDA has decided the death was important enough to mention on Tecfidera labels. The ...
 FierceMedicalDevices3 weeks ago FDA adds PML death scenario to Tecfidera label  FiercePharma3 weeks ago FDA amends label of Biogen Idec's Tecfidera to warn of a case of PML  FirstWord Pharma3 weeks ago Biogen Idec reports death of patient that had taken its multiple sclerosis pill Tecfidera  Boston Globe2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less